Investigational Drugs List

Groups Distribution
Phase Distribution
Filter Conditions

Investigational Drugs List

Drugs ID CID Drugs Identifier Molecular Formula Molecular Weight Groups US Approved Details
Drug31 4477 Niclosamide NCT03521232 C13H8Cl2N2O4 327.12 approved NO Details
Drug32 4594 Omeprazole NCT01287195, NCT02760615, NCT03358706 C17H19N3O3S 345.40 approved|investigational YES Details
Drug33 4595 Ondansetron NCT05439772 C18H19N3O 293.40 approved YES Details
Drug34 4740 Pentoxifylline NCT01438372 C13H18N4O3 278.31 approved|investigational YES Details
Drug35 4927 Promethazine NCT02765256 C17H20N2S 284.40 approved YES Details
Drug36 5042 Rebamipide NCT00463151 C19H15ClN2O4 370.80 NULL NULL Details
Drug37 5234 Saline NCT02998112, NCT06874673 ClNa 58.44 NULL YES Details
Drug38 5243 Picosulfuric Acid NCT02009202 C18H15NO8S2 437.40 NULL YES Details
Drug39 5426 Thalidomide NCT06382519, NCT00720538 C13H10N2O4 258.23 approved|investigational|withdrawn YES Details
Drug40 5743 Dexamethasone NCT03456752, NCT00152620 C22H29FO5 392.50 approved|investigational YES Details